Trial Profile
Randomized, Double-Blind, Study to Assess Low-Dose Naltrexone and Acetaminophen Combination in the Prevention of Episodic Migraine in Adults
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 11 Apr 2024
Price :
$35
*
At a glance
- Drugs ALLOD 2 (Primary)
- Indications Migraine
- Focus Proof of concept; Therapeutic Use
- Acronyms ANODYNE-3
- Sponsors Allodynic Therapeutics
- 11 Apr 2021 Status changed from active, no longer recruiting to completed.
- 14 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 29 Oct 2017 Planned number of patients changed from 48 to 12.